UBS has reiterated its recommendation to 'buy' Microsoft, with a price target of $510, indicating a potential growth of 22% for the stock.

The brokerage emphasizes the positive impact of increased Azure revenues resulting from the partnership with OpenAI, stating that this growth outweighs any potential effects on earnings per share (EPS).

Furthermore, UBS suggests that if the exclusive computing agreement is relaxed, it could be advantageous for Microsoft. This analysis demonstrates confidence in Microsoft's strategic relationship with OpenAI and its potential for future revenue growth.